Expression of HPV L1 capsid protein in cervical specimens with HPV infection

Diagnostic Cytopathology

Volumn 36, Issue 12, 2008, Pages 864-867

  Lee, Heejeong ^a   Lee, Kyung Ji ^a   Jung, Chan Kwon ^a   Hong, Jae Hwa ^a   Lee, Youn Soo ^a   Choi, Young Jin ^a   Lee, Kyo Young ^a   Park, Gyeongsin ^a,b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Human papillomavirus; Immunostaining; L1 capsid protein; Uterine cervical specimens

Indexed keywords

CAPSID PROTEIN; L1 CAPSID PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOLOGY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX; VIRUS INFECTION; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CAPSID PROTEINS; FEMALE; HUMANS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; UTERINE CERVICAL DYSPLASIA; VAGINAL SMEARS;

EID: 57349136765     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.20922     Document Type: Article

References (19)

1. Kumar V, Abbas AK, Fausto N. Robbins and Cotran pathologic basis of disease. 7th ed. Philadelphia: Elsevier Saunders; 2002.
2. Kurman RJ. Blaustein's pathology of the female genital tract. 5th ed. NewYork: Springer; 2002.
3. Melsheimer P, Kaul S, Dobeck S, Bastert G. Immunocytochemical detection of HPV high-risk type L1 capsid proteins in LSIL and HSIL as compared with detection of HPV L1 DNA. Acta Cytol 2003;47:124-128.
4. Griesser H, Sander H, Hilfrich R, Moser B, Schenck U. Correlation of immunochemical detection of HPV L1 capsid protein in pap smears with regression of high-risk HPV positive mild/moderate dysplasia. Anal Quant Cytol Histol 2004;26:241-245.
5. Ho GY, Bierman R, Beardsley L, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-428.
6. Moscicki AB, Shiboski S, Broering J, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998;132:277-284.
7. Sun XW, Kuhn L, Ellerbrock TV, et al. Human papillomavirus infection in HIV-seropositive women: Natural history and variability of detection. N Engl J Med 1997;337:1343-1349.
8. Ellerbrock TV, Chiasson MA, Bush TJ, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000;283:1031-1037.
9. Hopman EH, Rozendaal L, Voorhorst FJ, et al. High risk human papillomavirus in women with normal cervical cytology prior to the development of abnormal cytology and colposcopy. Br J Obstet Gynaecol 2000;107:600-604.
10. Wallin KL, Wiklund F, Angstrom T, et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999;341:1633-1638.
11. Nasiell K, Roger V, Nasiell M. Behavior pf mild cervical dysplasia during long-term follow-up. Obstet Gynecol 1986;67:665-669.
12. Campion MJ, McCance DJ, Cuzick J, et al. Progressive potential of mild cervical atypia:prospective cytological, colposcopic, and virologic study. Lancet 1986;2:237-240.
13. Greenberg MD, Reid R, Schiffman M, et al. A prospective study of biopsy-confirmed cervical intraepithelial neoplasia grade 1:colposcopic, cytological, and virological risk factors for progression. J Lower Genit Tract Dis 1999;3:104-110.
14. Heinzl S, Szalmay G, Jochum L, et al. Observations on the development of dysplasia. Acta Cytol 1982;26:453-456.
15. Kataja V, Syrjanen S, Mantyjarvi R, et al. Prognostic factor in cervical human papillomavirus infections. Sex Transm Dis 1992;19:154-160.
16. Robertson JH, Woodend BE, Crozier EH, et al. Risk of cervical cancer associated with mild dyskaryosis. Br Med J 1988;297:18-21.
17. Lawson HW, Lee NC, Thames SF, et al. Cervical cancer screening among low-income women: Results of a national screening program, 1991-1995. Obset Gynecol 1998;92:745-752.
18. Sadeghi SB, Sadeghi A, Robboy SJ. Prevalence of dysplasia and cancer of the cervix in a nationwide Planned Parenthood population. Cancer (Phila) 1988;61:2359-2361.
19. Kinney WK, Manos MM, Hurley LB, et al. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol 1998;91:973-976.